MCKECHNIE DUNCAN (EVP, Chief Commercial Officer) reported 1 transaction at VERTEX PHARMACEUTICALS INC / MA
Review the transaction codes below to understand the nature of each event.
Filed: 2/12/2026ACC: 0000875320-26-000048
Officer· EVP, Chief Commercial Officer
Since Mar 2026
-1.13K
Net shares
Net seller
$527.9K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.13K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.13K
Price / share
$468.41
Trade value
$527.90K
% of position
4.9%
2/10/2026
22.94K→21.81K
Total
Net shares
−1.13K
Net value
-$527.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | F · Tax Withholding | −1.13K | $468.41 | $527.90K | 4.9% | 22.94K | 21.81K |
| Total | −1.13K | -$527.90K | ||||||
Derivative Transactions0
No derivative transactions reported